Assessment of patients with metastatic transitional cell carcinoma of the urinary tract.

[1]  H. Hansen,et al.  The Radner needle a bone-marrow biopsy device. , 2009, Scandinavian journal of haematology.

[2]  I. Tannock,et al.  Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  S. Fosså,et al.  Survival of patients with advanced urothelial cancer treated with cisplatin-based chemotherapy. , 1996, British Journal of Cancer.

[4]  L. Sengeløv,et al.  Assessment of functional status in patients with invasive carcinoma of the urothelial tract. , 1996, Urologic oncology.

[5]  H. Grossman,et al.  The relationship of local control to distant metastasis in muscle invasive bladder cancer. , 1995, The Journal of urology.

[6]  C. Kamby,et al.  1163 Pattern of metastases in relation to characteristics of primary tumor and treatment in patients (pts) with disseminated urothelial carcinoma (UC) , 1995 .

[7]  V. Rangnekar,et al.  Identification of bone marrow micrometastases in patients with prostate cancer , 1994, Cancer.

[8]  L. Sengeløv,et al.  Prognostic factors and significance of chemotherapy in patients with recurrent or metastatic transitional cell cancer of the urinary tract , 1994, Cancer.

[9]  R. Edelman,et al.  Magnetic resonance imaging (2) , 1993, The New England journal of medicine.

[10]  Steinberg Gd,et al.  Metastatic bladder cancer. Natural history, clinical course, and consideration for treatment. , 1992 .

[11]  Wishnow Ki,et al.  Will Rogers and the results of radical cystectomy for invasive bladder cancer. , 1991 .

[12]  N. Geller,et al.  Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy , 1991, Cancer.

[13]  O. S. Nielsen,et al.  Bone metastases: pathophysiology and management policy. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  P. R. Timmer,et al.  Bladder cancer: pattern of recurrence in 142 patients. , 1985, International journal of radiation oncology, biology, physics.

[15]  R. Babaian,et al.  Metastases from transitional cell carcinoma of urinary bladder. , 1980, Urology.

[16]  W. Shipley,et al.  Bladder carcinoma as a systemic disease , 1979, Cancer.

[17]  J. Madewell,et al.  Metastatic transitional cell carcinoma from the bladder: radiographic manifestions. , 1979, AJR. American journal of roentgenology.

[18]  G. Moberger,et al.  Classification of bladder tumours based on the cellular pattern. Preliminary report of a clinical-pathological study of 300 cases with a minimum follow-up of eight years. , 1965, Acta chirurgica Scandinavica.

[19]  H. von der Maase,et al.  Pattern of metastases in relation to characteristics of primary tumor and treatment in patients with disseminated urothelial carcinoma. , 1996, The Journal of urology.

[20]  S. Fosså,et al.  Clinical significance of routine pre-cystectomy bone scans in patients with muscle-invasive bladder cancer. , 1996, British journal of urology.

[21]  R. D. Hunter,et al.  WHO Handbook for Reporting Results of Cancer Treatment , 1980 .